Naphthyridine derivatives
US5712286A · kind A · utility
2Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 1997 |
| Grant date | Jan 27, 1998 |
| Priority date | — |
| Expiry date | Mar 24, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) including pharmaceutically acceptable salts thereof in which R.sub.1 represents a C.sub.1-6 alkyl group; R.sub.2 represents a group of the formula COOR.sub.4 in which R.sub.4 represents a C.sub.1-5 alkyl group; and R.sub.3 represents a group of formula COOR.sub.5 in which R.sub.5 represents a C.sub.1-5 alkyl group are disclosed, which are anti-rheumatic agents and are useful as modulators of cytokine synthesis, immunomodulatory agents, anti-inflammatory agents and anti-allergic agents. Compositions containing these compounds and processes to make these compounds are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.